Biology Reference
In-Depth Information
McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD (2006) p16(INK4a)
prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 4:e51
Metge B, Ofori-Acquah S, Stevens T, Balczon R (2004) Stat3 activity is required for centrosome
duplication in Chinese hamster ovary cells. J Biol Chem 279:41801-41806
Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE (2002) p53 and p21 form
an
inducible
barrier
that
protects
cells
against
cyclin
E-cdk2
deregulation.
Curr
Biol
12:1817-1827
Momand J, Zambetti G (1997) Mdm-2: ''big brother'' of p53. J Cell Biochem 64:343-352
Mussman JG, Horn HF, Carroll PE, Okuda M, Donehower LA, Fukasawa K (2000) Synergistic
induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
Oncogene 19:1635-1946
Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996) ROCK-I and ROCK-
II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in
mice. FEBS Lett 392:189-193
Nam HJ, Chae S, Jang SH, Cho H, Lee JH (2010) The PI3 K-Akt mediates oncogenic Met-
induced centrosome amplification and chromosome instability. Carcinogenesis 31:1531-1540
Nevis KR, Cordeiro-Stone M, Cook JG (2009) Origin licensing and p53 status regulate Cdk2
activity during G(1). Cell Cycle 15:1952-1963
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan P-K, Knudsen ES, Hofmann
IA, Snyder JD, Bove KE, Fukasawa K (2000) Nucleophosmin/B23 is a target of CDK2-cyclin
E in centrosome duplication. Cell 103:127-140
Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa
T, Hirao T, Nakano H (1998) Prognostic value of cyclin E and p53 expression in gastric
carcinoma. Cancer 82:1238-1243
Sherline P, Mascardo RN (1982) Epidermal growth factor induces rapid centrosomal separation
in HeLa and 3T3 cells. J Cell Biol 93:507-512
Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6:663-673
Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase
progression. Genes Dev 13:1501-1512
Sugihara E, Kanai M, Saito S, Nitta T, Toyoshima H, Nakayama K, Nakayama KI, Fukasawa K,
Schwab M, Saya H, Miwa M (2006) Suppression of centrosome amplification after DNA
damage depends on p27 accumulation. Cancer Res 66:4020-4029
Tarapore P, Horn HF, Tokuyama Y, Fukasawa K (2001) Direct regulation of the centrosome
duplication cycle by the p53-p21
Waf1/Cip1
pathway. Oncogene 20:3173-3184
Tarapore P, Okuda M, Fukasawa K (2002) A mammalian in vitro centriole duplication system:
Evidence
for
involvement
of
CDK2/cyclin
E
and
Nucleophosmin/B23
in
centrosome
duplication. Cell Cycle 1:75-81
Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803-1815
Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Brinkley BR, Roop DR (1998) Analysis of
centrosome abnormalities and angiogenesis in epidermal-targeted p53 172H mutant and p53-
knockout mice after chemical carcinogenesis: evidence for a gain of function. Mol Carcinog
23:185-192
Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
Exp Cell Res 301:43-49
Zeng X, Shaikh FY, Harrison MK, Adon AM, Trimboli AJ, Carroll KA, Sharma N, Timmers C,
Chodosh LA, Leone G, Saavedra HI (2010) The Ras oncogene signals centrosome
amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene
29:5103-5112
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumour
amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transfor-
mation. Nat Genet 20:189-193
